Skip to Main Content
rows of glass bottles filled with medicines and plugged with cork stoppers
Food & Drug Law (Including Tobacco Control)

This thematic area examines how to effectively regulate different products and their marketing to protect and promote the public health. The scope of our research includes foods, drugs (including legalized cannabis), biologics, and tobacco products (including e-cigarettes).

Featured Project

Public Health Approaches to Marijuana Legalization

The O’Neill Institute for National and Global Health Law, in collaboration with the Washington Office on Latin America (WOLA), has received a grant from the Open Philanthropy Project to help develop guidelines on how states, countries, and other jurisdictions that opt to legalize cannabis for medical or recreational purposes can create regulatory frameworks, consistent with the goals of legalization, that will work effectively to protect and promote the public health.

Active Projects

Selected Publications
Lindblom, Eric N. “How FDA Could Use Its Existing Authorities to Make State Legalization of Cannabis More Safe and Effective.” Food & Drug Law Journal 74, no. 2 (April 2019).
Lindblom, Eric N. “Should FDA Try to Move Smokers to E-Cigarettes and Other Less-Harmful Tobacco Products and, If So, How?” Food & Drug Law Journal 73, no. 2 (May 31, 2018): 276–318.
Lindblom, Eric N. “Are There Any Ethical Barriers to Effective Antismoking Measures.” AJPH 107, no. 9 (September 2017): 1364–65.
Lindblom, Eric N. “How Might Manufacturers of E-Cigarettes Get New Product and MRTP Orders from FDA More Quickly and Easily?” Food & Drug Law Journal, Posted with consent from the Food & Drug Law Journal and the Food & Drug Law Institute, 73, no. 4 (December 2018): 624–41.
Lindblom, Eric N. “Filling in the Blanks on Reducing Tobacco Product Addictiveness in the FCTC Partial Guidelines for Articles 9 & 10.” O’Neill Institute Working Paper No. 1, November 17, 2014.

View all Publications

Completed Projects